Global Pharma Company Partners with Panalgo to Bring Greater Equity to Clinical Trials

This case study describes a global pharmaceutical company using Panalgo's Instant Health Data (IHD) platform to improve analytics and real-world-evidence generation in the context of clinical trial diversity. The page states the team achieved "unparalleled cost savings and unlocked new levels of productivity – without hiring more staff or outsourcing their projects," and notes IHD "has already transformed the research landscape for many top 20 life sciences teams." This is a promotional landing page rather than a full report: no concrete numerical metrics are shown, as detailed figures require downloading the full case study via a form.

The customer is anonymised in Norstella’s own case study — not withheld by us.

Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.